Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties

Despite the progress of the bioinformatics approach to characterize cell-surface antigens and receptors on tumor cells, it remains difficult to generate novel cancer vaccines or neutralizing monoclonal antibody therapeutics. Among targeted cancer therapeutics, biologicals with targetable antibodies...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, Koji, Nakajima, Oumi, Morishita, Ryuichi, Nagai, Ryozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: TheScientificWorldJOURNAL 2006
Materias:
Mini-Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917189/
https://www.ncbi.nlm.nih.gov/pubmed/16830050
http://dx.doi.org/10.1100/tsw.2006.162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917189/
https://www.ncbi.nlm.nih.gov/pubmed/16830050
http://dx.doi.org/10.1100/tsw.2006.162

Ejemplares similares